» Articles » PMID: 16936228

Cannabinoid Receptor-mediated Apoptosis Induced by R(+)-methanandamide and Win55,212-2 is Associated with Ceramide Accumulation and P38 Activation in Mantle Cell Lymphoma

Overview
Journal Mol Pharmacol
Date 2006 Aug 29
PMID 16936228
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently shown that cannabinoids induce growth inhibition and apoptosis in mantle cell lymphoma (MCL), a malignant B-cell lymphoma that expresses high levels of cannabinoid receptor types 1 and 2 (CB(1) and CB(2)). In the current study, the role of each receptor and the signal transduction triggered by receptor ligation were investigated. Induction of apoptosis after treatment with the synthetic agonists R(+)-methanandamide [R(+)-MA] and Win55,212-2 (Win55; (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo-[1,2,3-d,e]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone) was dependent on both cannabinoid receptors, because pretreatment with N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboximide hydrochloride (SR141716A) and N-((1S)-endo-1,3,3-trimethyl bicyclo heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide) (SR144528), specific antagonists to CB(1) and CB(2), respectively, abrogated caspase-3 activity. Preincubation with the inhibitors 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole (SB203580) and 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole (SB202190) showed that phosphorylation of MAPK p38 was implicated in the signal transduction leading to apoptosis. Treatment with R(+)-MA and Win55 was associated with accumulation of ceramide, and pharmacological inhibition of ceramide synthesis de novo prevented both p38 activation and mitochondria depolarization assessed by binding of 3,3'-dihexyloxacarbocyanine iodide (DiOC(6)). In contrast, the pancaspase inhibitor z-Val-Ala-Asp(Ome)-CH(2)F (z-VAD-FMK) did not protect the mitochondrial integrity. Taken together, these results suggest that concurrent ligation of CB(1) and CB(2) with either R(+)-MA or Win55 induces apoptosis via a sequence of events in MCL cells: accumulation of ceramide, phosphorylation of p38, depolarization of the mitochondrial membrane, and caspase activation. Although induction of apoptosis was observed in both MCL cell lines and primary MCL, normal B cells remained unaffected. The present data suggest that targeting CB(1)/CB(2) may have therapeutic potential for the treatment of mantle cell lymphoma.

Citing Articles

Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines.

Omer S, Pathak S, Mansour M, Nadar R, Bowen D, Dhanasekaran M Biomolecules. 2024; 14(4).

PMID: 38672512 PMC: 11047936. DOI: 10.3390/biom14040495.


Sphingolipids and Lymphomas: A Double-Edged Sword.

Pherez-Farah A, Lopez-Sanchez R, Villela-Martinez L, Ortiz-Lopez R, Beltran B, Hernandez-Hernandez J Cancers (Basel). 2022; 14(9).

PMID: 35565181 PMC: 9104519. DOI: 10.3390/cancers14092051.


Expression and Functions of the CB Receptor in Human Leukocytes.

Simard M, Rakotoarivelo V, Di Marzo V, Flamand N Front Pharmacol. 2022; 13:826400.

PMID: 35273503 PMC: 8902156. DOI: 10.3389/fphar.2022.826400.


Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?.

Garmpis N, Damaskos C, Dimitroulis D, Garmpi A, Diamantis E, Sarantis P In Vivo. 2022; 36(2):543-555.

PMID: 35241505 PMC: 8931882. DOI: 10.21873/invivo.12736.


Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence.

Verma R, Hoda F, Arshad M, Iqubal A, Siddiqui A, Ahmed Khan M Med Cannabis Cannabinoids. 2021; 4(1):43-60.

PMID: 34676349 PMC: 8525216. DOI: 10.1159/000515042.